Clinical Trial Update: Thailand ATTR-CM Registry

View source ↗

Summary

A Mahidol University–sponsored clinical trial registry entry for Transthyretin amyloid cardiomyopathy (ATTR-CM) is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Transthyretin Amyloid Cardiomyopathy

Snippet

Sponsor: Mahidol University | Conditions: Transthyretin Amyloid Cardiomyopathy (ATTR-CM) | Status: RECRUITING